aesthetic-medicine-ent-conference-2017-keynote

10 / 10

Volume 7, Issue 4 (Suppl) Otolaryngology
ISSN: 2161-119X Otolaryngology, an open access journal Aesthetic Medicine & ENT Conference 2017
July 06-08, 2017
Page 35
Notes:
conferenceseries.com
July 06-08, 2017 Kuala Lumpur, Malaysia
International Conference on
Aesthetic Medicine and ENT
The use of oral probiotics in the prevention of upper respiratory tract infections
At the start of the 20th century (in 1908), Russian Noble Prize winner and Father of Modern Immunology, E. Metchnikoff,
a scientist at the Pasteur Institute, observed that a surprising number of people in Bulgaria lived more than 100 years.
Metchnikoff observed that Bulgarian peasants consumed large quantities of “yogurt”. He subsequently isolated bacteria from
the yogurt and determined that they conferred the observed health-promoting benefits. The clinical evidence for application
of the interfering ability of non-virulent bacteria to prevent or treat infections has been rather limited, although promising
for certain purposes. Bacterial interference refers to the antagonism between bacterial species during the process of surface
colonisation and acquisition of nutrients. Conventionally, probiotics, defined by the WHO as ‘live organisms which, when
administered in adequate amounts confer a health benefit on the host’, have almost exclusively been bacteria of intestinal
origin, and their application has largely been targeted at relieving maladies of the gastrointestinal tract. A number of relevant
preliminary trials suggest that in the upper respiratory tract the rate of recurrence of Streptococcal pharyngotonsillitis appears
to decrease using selected bacteria with inhibitory ability against common pathogens of upper respiratory tract. Sore throat is
one of the most common reasons for visits to family physicians or paediatrician. URTIs are very common and cause substantial
illness and billions of dollars of economic loss every year. Streptococcus pyogenes is a major cause of acute pharyngeal infections,
especially in children. Oral probiotic as Streptococcus salivarius K12 has been shown clearly to antagonize the growth of
Streptococcus pyogenes, the most important bacterial cause of pharyngeal infections in humans, by releasing two bacteriocins
named Salivaricin A2 and Salivaricin B, reducing the incidence of Streptococcal pharyngitis and/or tonsillitis. According to
our reviews of the literature and our experience prophylactic administration of Streptococcus salivarius K12 to adults and/or
children having a history of recurrent oral streptococcal pathology reduces the number of episodes of streptococcal pharyngeal
infections and/or tonsillitis.
Biography
Alessandro Bucci is the Head of Sleep Apnea Center and Rhinology/Rhino-Allergology Center - Otolaryngology department, ASUR Marche, AV2 – Senigallia, Italy.
He is an International Faculty Member of the XXXV Pan-American Congress of Otorhinolaryngology 2016, Cuba, Past Director of the International Conference on
Rhinology and Rhino-Allergology/5th Bulgarian Italian Rhinology Meeting, 2016 Senigallia (Italy), Committee Member and Chairman of the International Specialists
Conference on Ear, Nose and Throat Disorders, November 2016 Alicante (Spain). In the past, he was a University Professor at the UNIVPM, Ancona, Italy. He
attended Medical school at Catholic University (UCSC) in Rome, and completed his Residency in Otolaryngology-Head and Neck Surgery at UCSC - Gemelli
Hospital in Rome. He is a Reserve Medical Officer of the Italian Navy and Consultant in Otolaryngology from 2002. He obtained PhD (in Rhinology and Rhino-
Allergology) in 2006 at UCSC, Rome and a Fellowship in Otolaryngology in Spain (University Hospital, Cadiz). He held Fellowships in Facial Plastic Surgery (AMC)
and OSAS (Sint Lucas Andreas Hospital) in Amsterdam, The Netherlands, and in Facial Plastic Surgery in Calixto Garcia University Hospital, La Habana, Cuba.
He is Vice-president of the ONLUS association: (National Association of Tracheotomised Patients) and is a Member of the ERS (European Rhinologic
Society).
Alessandro Bucci
ASUR Marche, Italy
Alessandro Bucci, Otolaryngology 2017, 7:4 (Suppl)
DOI: 10.4172/2161-119X-C1-018